Literature DB >> 19321629

Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.

Clifford M Cassidy1, Ross Norman, Rahul Manchanda, Norbert Schmitz, Ashok Malla.   

Abstract

BACKGROUND: To determine the clinical relevance of different definitions of symptom remission for prediction of functional outcome in first-episode psychosis (FEP).
METHODS: One hundred forty-one individuals receiving treatment for an FEP at a specialized early intervention service had positive and negative symptoms and functional status rated every month over the first 2 years of treatment using the Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms, and Social and Occupational Functioning Assessment Scale. Subjects were classified according to 4 definitions of remission varying the criteria for severity (negative symptom inclusion/exclusion) and duration (3/6 mo sustained).
RESULTS: Positive symptom remission was achieved by 94% and 84% of subjects for 3 and 6 months, respectively, compared with 70% and 56% for positive and negative symptom remission, respectively. Linear regression analyses showed that only definitions of remission containing both positive and negative symptoms independently predicted functional outcome. This was confirmed by receiver operating characteristic analyses where remission based on positive and negative symptoms was marginally better than positive symptoms alone (difference in area under the curve; z = 1.94, P = .052). There was little difference between a time criterion of remission of positive and negative symptoms of 3 (sensitivity = 100%, specificity = 42%) or 6 (sensitivity = 90%, specificity = 57%) months. DISCUSSION: Consistent with the consensus definition of remission in schizophrenia, severity of both positive and negative symptoms in defining remission in FEP is necessary although a 3-month criterion had equal predictive validity to the 6-month criterion.

Entities:  

Mesh:

Year:  2009        PMID: 19321629      PMCID: PMC2930352          DOI: 10.1093/schbul/sbp007

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  27 in total

1.  Reliability of the life chart schedule for assessment of the long-term course of schizophrenia.

Authors:  E Susser; M Finnerty; R Mojtabai; S Yale; S Conover; R Goetz; X Amador
Journal:  Schizophr Res       Date:  2000-03-16       Impact factor: 4.939

2.  A Canadian programme for early intervention in non-affective psychotic disorders.

Authors:  Ashok Malla; Ross Norman; Terry McLean; Derek Scholten; Laurel Townsend
Journal:  Aust N Z J Psychiatry       Date:  2003-08       Impact factor: 5.744

3.  Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study.

Authors:  Ashok Malla; Ross Norman; Norbert Schmitz; Rahul Manchanda; Laura Béchard-Evans; Jatinder Takhar; Raj Haricharan
Journal:  Psychol Med       Date:  2006-03-06       Impact factor: 7.723

Review 4.  First-episode psychosis: psychopathology, quality of life, and functional outcome.

Authors:  Ashok Malla; Jennifer Payne
Journal:  Schizophr Bull       Date:  2005-07-08       Impact factor: 9.306

5.  Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.

Authors:  Robert A Lasser; Cynthia A Bossie; Georges M Gharabawi; John M Kane
Journal:  Schizophr Res       Date:  2005-09-15       Impact factor: 4.939

6.  Remission and cognitive ability in a cohort of patients with schizophrenia.

Authors:  Lars Helldin; John M Kane; Ulla Karilampi; Torsten Norlander; Trevor Archer
Journal:  J Psychiatr Res       Date:  2006-09-11       Impact factor: 4.791

7.  Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

Authors:  B C Ho; N C Andreasen; M Flaum; P Nopoulos; D Miller
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

8.  Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version).

Authors:  A K Malla; R M Norman; T S McLean; E McIntosh
Journal:  Acta Psychiatr Scand       Date:  2001-05       Impact factor: 6.392

9.  Validation of remission criteria for schizophrenia.

Authors:  Jim van Os; Marjan Drukker; Joost à Campo; Jaap Meijer; M Bak; Philippe Delespaul
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

10.  The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Authors:  John M Kane; Stefan Leucht; Daniel Carpenter; John P Docherty
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

View more
  25 in total

1.  Evaluation of a multi-element treatment center for early psychosis in the United States.

Authors:  Sarah R Uzenoff; David L Penn; Karen A Graham; Sylvia Saade; Barbara B Smith; Diana O Perkins
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-01-26       Impact factor: 4.328

2.  A carer's perspective: the view from Australia.

Authors:  Paul Kauffman
Journal:  Schizophr Bull       Date:  2013-07-20       Impact factor: 9.306

Review 3.  Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.

Authors:  M Alvarez-Jimenez; B O'Donoghue; A Thompson; J F Gleeson; S Bendall; C Gonzalez-Blanch; E Killackey; L Wunderink; P D McGorry
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

Review 4.  Relapse risk assessment in early phase psychosis: the search for a reliable and valid tool.

Authors:  Phil Tibbo; Ashok Malla; Rahul Manchanda; Richard Williams; Ridha Joober
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

5.  "Will I need to take these medications for the rest of my life?"

Authors:  Stephen R Marder; Michael F Zito
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

6.  The role of cognition in outcome in schizophrenia and related disorders.

Authors:  Ashok Malla
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

7.  Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial.

Authors:  Ashok Malla; Ridha Joober; Srividya Iyer; Ross Norman; Norbert Schmitz; Thomas Brown; Danyael Lutgens; Eric Jarvis; Howard C Margolese; Nicola Casacalenda; Amal Abdel-Baki; Eric Latimer; Sally Mustafa; Sherezad Abadi
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

8.  Advances and challenges in early intervention in psychosis.

Authors:  Ashok Malla; Jai Shah; Shalini Lal
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

Review 9.  Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research.

Authors:  Dost Öngür; Cameron S Carter; Raquel E Gur; Diana Perkins; Akira Sawa; Larry J Seidman; Carol Tamminga; Wayne Huggins; Carol Hamilton
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-06-29

10.  Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia.

Authors:  Amresh Shrivastava; Nilesh Shah; Megan Johnston; Larry Stitt; Meghana Thakar; Gurusamy Chinnasamy
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.